Current and Future Treatment Considerations in the Management of Aneurysmal Subarachnoid Hemorrhage
- 12 August 2010
- journal article
- review article
- Published by SAGE Publications in Journal of Pharmacy Practice
- Vol. 23 (5) , 408-424
Abstract
Aneurysmal subarachnoid hemorrhage (aSAH) is a type of hemorrhagic stroke that can cause significant morbidity and mortality. Although guidelines have been published to help direct the care of these patients, there is insufficient quality literature regarding the medical and pharmacological management of patients with aSAH. Treatment is divided into 3 categories: supportive therapy, prevention of complications, and treatment of complications. There are numerous pharmacological therapies that are targeted at prevention and treatment of the neurological and medical complications that may arise. Rebleeding, hydrocephalus, cerebral vasospasm, and seizures are the most common neurological complications while the most common medical complications include hyponatremia, pulmonary edema, cardiac arrhythmias, neurogenic stunned myocardium, fever, anemia, infection, hyperglycemia, and venous thromboembolism. Risk factors, clinical presentation, diagnosis, pathophysiology, as well as initial management, prevention, and treatment of complications will be the focus of this discussion.Keywords
This publication has 139 references indexed in Scilit:
- Factors Associated with the Development of Anemia After Subarachnoid HemorrhageNeurocritical Care, 2009
- Risk of recurrent subarachnoid haemorrhage, death, or dependence and standardised mortality ratios after clipping or coiling of an intracranial aneurysm in the International Subarachnoid Aneurysm Trial (ISAT): long-term follow-upThe Lancet Neurology, 2009
- Prehemorrhage statin use and the risk of vasospasm after aneurysmal subarachnoid hemorrhageSurgical Neurology, 2009
- Is reducing variability of blood glucose the real but hidden target of intensive insulin therapy?Critical Care, 2009
- Simvastatin attenuation of cerebral vasospasm after subarachnoid hemorrhage in rats via increased phosphorylation of Akt and endothelial nitric oxide synthaseJournal of Neuroscience Research, 2008
- Complications associated with anemia and blood transfusion in patients with aneurysmal subarachnoid hemorrhageCritical Care Medicine, 2008
- Endothelin-1 in plasma, cisternal CSF and microdialysate following aneurysmal SAHActa Neurochirurgica, 2005
- The impact of cardiac complications on outcome in the SAH populationActa Neurologica Scandinavica, 2004
- Risk of Cerebral Angiography in Patients With Subarachnoid Hemorrhage, Cerebral Aneurysm, and Arteriovenous MalformationStroke, 1999
- Antifibrinolytic Treatment in Subarachnoid HemorrhageNew England Journal of Medicine, 1984